While Grace Therapeutics Inc has overperformed by 1.34%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GRCE fell by -18.98%, with highs and lows ranging from $4.97 to $1.75, whereas the simple moving average fell by -1.55% in the last 200 days.
On May 02, 2025, TD Cowen started tracking Grace Therapeutics Inc (NASDAQ: GRCE) recommending Buy. A report published by Oppenheimer on September 01, 2020, Downgraded its rating to ‘Perform’ for GRCE. B. Riley FBR also Upgraded GRCE shares as ‘Buy’, setting a target price of $2 on the company’s shares in a report dated July 06, 2020. B. Riley FBR initiated its ‘Buy’ rating for GRCE, as published in its report on August 29, 2019. Oppenheimer’s report from July 18, 2019 suggests a price prediction of $7 for GRCE shares, giving the stock a ‘Outperform’ rating. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of Grace Therapeutics Inc (GRCE)
Grace Therapeutics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -16.78% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 8.87, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and GRCE has an average volume of 71.24K. On a monthly basis, the volatility of the stock is set at 6.82%, whereas on a weekly basis, it is put at 6.38%, with a loss of -6.77% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.83, showing growth from the present price of $3.03, which can serve as yet another indication of whether GRCE is worth investing in or should be passed over.
How Do You Analyze Grace Therapeutics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 26.93%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 27.60% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
